PRKAA2 and metabolic dysfunction-associated steatotic liver disease: Therefore, developing therapeutic strategies that precisely modulate the AMPK signaling pathway through a deeper understanding of AMPK regulatory mechanisms holds significant importance for expanding treatment options for MASLD.